DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 59 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $621,728 | +15.7% | 39,525 | -6.4% | 0.00% | -20.0% |
Q3 2023 | $537,267 | -12.5% | 42,238 | +27.3% | 0.01% | -61.5% |
Q3 2022 | $614,000 | +34.9% | 33,187 | -32.4% | 0.01% | +18.2% |
Q1 2022 | $455,000 | -36.2% | 49,084 | +208.9% | 0.01% | -21.4% |
Q1 2021 | $713,000 | -60.8% | 15,890 | -50.1% | 0.01% | -72.5% |
Q4 2020 | $1,817,000 | +81.9% | 31,831 | -39.5% | 0.05% | +104.0% |
Q3 2017 | $999,000 | – | 52,630 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |